Orchid Pharma Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	996.57	921.67	463.18	-19.51	-1,165
Depreciation & Amortization	343.77	321.07	547.79	869.93	1,089
Other Amortization	1.69	11.31	0.08	0.31	0.32
Loss (Gain) From Sale of Assets	3.2	1.88	-399.85	-0	0.65
Loss (Gain) From Sale of Investments	-	-	-0.15	-5.12	-19.42
Loss (Gain) on Equity Investments	-38.99	28.98	21.54	35.23	-
Provision & Write-off of Bad Debts	68.41	-2.65	11.88	36.67	13.28
Other Operating Activities	-97.17	56.05	329.54	298.27	611.43
Change in Accounts Receivable	-490.66	196.47	-416.54	-229.19	-820.25
Change in Inventory	-621.45	-354.88	-560.82	25.37	-334.99
Change in Accounts Payable	-67.82	548.51	139.14	473.63	179.31
Change in Other Net Operating Assets	94.61	-468.48	47.59	325.86	606.33
Operating Cash Flow	192.15	1,260	183.38	924.75	235.86
Operating Cash Flow Growth	-84.75%	587.05%	-80.17%	292.07%	-70.81%
Capital Expenditures	-1,501	-648.15	-849.13	-144.04	-6.04
Sale of Property, Plant & Equipment	-	-	585.46	0.99	2.86
Divestitures	-	-	-	1,594	-
Investment in Securities	1,044	-2,592	-53.07	-326.55	668.52
Other Investing Activities	187.39	120.02	4.61	4.88	6.71
Investing Cash Flow	-269.32	-3,120	-312.14	1,129	672.05
Long-Term Debt Issued	285.56	-	1,732	199.99	-
Total Debt Issued	285.56	-	1,732	199.99	-
Long-Term Debt Repaid	-2.21	-2,200	-1,098	-2,048	-1,251
Total Debt Repaid	-2.21	-2,200	-1,098	-2,048	-1,251
Net Debt Issued (Repaid)	283.35	-2,200	633.92	-1,848	-1,251
Issuance of Common Stock	-	3,919	-	-	-
Other Financing Activities	-31.13	-48.96	-322.26	-320.12	-399.09
Financing Cash Flow	252.22	1,670	311.66	-2,168	-1,650
Net Cash Flow	175.05	-189.96	182.91	-113.87	-741.98
Free Cash Flow	-1,309	611.77	-665.75	780.71	229.82
Free Cash Flow Growth	-	-	-	239.71%	-69.98%
Free Cash Flow Margin	-14.20%	7.47%	-10.00%	13.95%	5.11%
Free Cash Flow Per Share	-25.81	12.65	-16.31	19.13	5.63
Cash Interest Paid	31.13	48.96	322.26	320.12	399.09
Cash Income Tax Paid	9.37	-6.29	2.99	19.06	-49.23
Levered Free Cash Flow	-749.27	-2,498	-1,048	2,206	100.7
Unlevered Free Cash Flow	-658.4	-2,396	-846.73	2,406	421.55
Change in Working Capital	-1,085	-78.38	-790.62	595.66	-369.6

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.